Need professional-grade analysis? Visit stockanalysis.com
$2.08B
N/A
485
N/A
Price Chart
Risk-Adjusted Performance
Fangzhou Inc (6086) Price Performance
Fangzhou Inc (6086) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at HKD1.33, down 3.62% from the previous close.
Over the past year, 6086 has traded between a low of HKD1.33 and a high of HKD5.24. The stock has lost 72.6% over this period. It is currently 74.6% below its 52-week high.
Fangzhou Inc has a market capitalization of $2.08B.
About Fangzhou Inc
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform; as well as operates hospitals. Fangzhou Inc. has a strategic collaboration with Youcare Pharmaceutical Group Co., Ltd. to accelerate the digital transformation and enhancement of chronic disease services through the application of artificial intelligence. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Exchange
- Hong Kong Stock Exchange
- Currency
- HKD
- Country
- Hong Kong
Financial Metrics
- Revenue (TTM)
- $2.88B
- EBITDA
- $7.60M
- Profit Margin
- -0.82%
- EPS (TTM)
- -0.02
- Book Value
- 0.13
Technical Indicators
- 52 Week High
- HK$6.20
- 52 Week Low
- HK$1.20
- 50 Day MA
- HK$2.50
- 200 Day MA
- HK$3.33
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 0.72
- Price/Book
- 12.37
- Enterprise Value
- $1.81B